Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1219-1224

  Lumiaho, Anne ^a   Pihlajamäki, Jussi ^b   Hartikainen, Juha ^b   Ikäheimo, Risto ^b   Miettinen, Raija ^b   Niemitukia, Lea ^b   Lampainen, Erkki ^b   Laakso, Markku ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Insulin resistance; Left ventricular hypertrophy (LVH); Left ventricular mass; Polycystic kidney disease (PKD)

Indexed keywords

ADULT; AGE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY WEIGHT; CALCULATION; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DIET RESTRICTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; EVALUATION; FAMILY; FEMALE; GLUCOSE BLOOD LEVEL; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART SIZE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY POLYCYSTIC DISEASE; LEFT VENTRICULAR MASS INDEX; M MODE ECHOCARDIOGRAPHY; MALE; MATHEMATICAL ANALYSIS; MULTIVARIATE ANALYSIS; PROTEINURIA; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY; SYSTOLIC BLOOD PRESSURE;

EID: 0037762874     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00354-8     Document Type: Article

References (36)

1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 2:630-639, 1983
2. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-894, 1994
3. Peters DJ, Sandkuijl LA: Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97:128-139, 1992
4. Wright AF, Teague PW, Pound SE, et al: A study of genetic linkage heterogeneity in 35 adult-onset polycystic kidney disease families. Hum Genet 90:569-571, 1993
5. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23. Genomics 18:467-472, 1993
6. Ravine D, Walker RG, Gibson RN, et al: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340:1330-1333, 1992
7. Torra R, Badenas C, Darnell A, et al: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7:2142-2151, 1996
8. The International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81:289-298, 1995
9. Mochizuki T, Wu G, Hayashi T, et al: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
10. De Almeida S, De Almeida E, Peters D, et al: Autosomal dominant polycystic kidney disease: Evidence for the existence of a third locus in a Portuguese family. Hum Genet 96:83-88, 1995
11. Daoust MC, Reynolds DM, Bichet G, Somlo S: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25:733-736, 1995
12. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA: Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 319:907-912, 1988
13. Timio M, Monarca C, Pede S, Gentili S, Verdura C, Lolli S: The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred. Clin Nephrol 37:245-251, 1992
14. Ivy DD, Shaffer EM, Johnson AM, Kimberling WJ, Dobin A, Gabow PA: Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:2032-2036, 1995
15. Saggar-Malik AK, Missouris CG, Gill JS, Singer DR, Markandu ND, MacGregor GA: Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 309:1617-1618, 1994
16. Leier CV, Baker PB, Kilman JW, Wooley CF: Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 100:683-688, 1984
17. Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8:1292-1297, 1997
18. Lumiaho A, Ikäheimo R, Miettinen R, et al: Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 38:1208-1216, 2001
19. Bardaji A, Vea AM, Gutierrez C, Ridao C, Richart C, Oliver JA: Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 32:970-975, 1998
20. McNulty PH, Louard RJ, Deckelbaum LI, Zaret BL, Young LH: Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance. Circulation 92:2151-2156, 1995
21. Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S: Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 83:4284-4288, 1998
22. Ohya Y, Abe I, Fujii K, et al: Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension 27:729-734, 1996
23. Vareesangthip K, Tong P, Wiilkinson R, Thomas TH: Insulin resistance in adult polycystic kidney disease. Kidney Int 52:503-508, 1997
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Trecher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083, 1978
26. Devereux RB: Echocardiography, hypertension, and left ventricular mass. Health Psychol 7:S89-S104, 1988 (suppl 7)
27. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 59:956-960, 1987
28. George VT, Elston RC: Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol 4:193-201, 1987
29. Bardaji A, Martinez-Vea A, Valero A, et al: Cardiac involvement in autosomal-dominant polycystic kidney disease: A hypertensive heart disease. Clin Nephrol 56:211-220, 2002
30. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL: Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 15:861-866, 1990
31. Vensel LA, Devereux RB, Pickering TG, Herrold EM, Borer JS, Laragh JH: Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 58:575-582, 1986
32. Teerlink JR: The evolving role of angiotensin-converting enzyme inhibition in heart failure: Expanding the protective envelope. J Cardiovasc Pharmacol 24:S32-S37, 1994 (suppl 3)
33. Lembo G, Napoli R, Capaldo B, et al: Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90:24-29, 1992
34. Rostrup M, Smith G, Bjornstad H, Westheim A, Stokland O, Eide I: Left ventricular mass and cardiovascular reactivity in young men. Hypertension 23:I168-I171, 1994
35. Bornfeldt KE, Skottner A, Arnqvist HJ: In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. J Endocrinol 135:203-211, 1992
36. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:2048-2056, 1995